Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association
暂无分享,去创建一个
R. Karr | J. Guenot | Z. Nagy | F. Sinigaglia | E. Bono | F. Gallazzi | J. Hammer | J Guenot | E Bono | F Gallazzi | Z A Nagy | F Sinigaglia | J Hammer | R W Karr | P Valsasnini | P. Valsasnini | Z. A. Nagy | Robert W. Karr | Juergen Hammer | Elisa Bono | Fabio Gallazzi
[1] J. Stewart. Solid Phase Peptide Synthesis , 1984 .
[2] F. Sinigaglia,et al. Promiscuous and allele-specific anchors in HLA-DR-binding peptides , 1993, Cell.
[3] J. Hansen,et al. Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[4] P. Kollman,et al. An all atom force field for simulations of proteins and nucleic acids , 1986, Journal of computational chemistry.
[5] M. Gefter,et al. Murine MHC polymorphism and T cell specificities. , 1989, Science.
[6] T. Glant,et al. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. , 1987, Arthritis and rheumatism.
[7] M S Doscher,et al. Solid-phase peptide synthesis. , 1977, Methods in enzymology.
[8] P. Bacon,et al. Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones , 1990, The Journal of experimental medicine.
[9] A. Kang,et al. Autoimmunity to type II collagen an experimental model of arthritis , 1977, The Journal of experimental medicine.
[10] Don C. Wiley,et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.
[11] R. Walsky,et al. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[12] Z. Nagy,et al. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.
[13] F. Sinigaglia,et al. Selection of T cell epitopes and vaccine engineering. , 1991, Methods in enzymology.
[14] P. Gregersen,et al. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.
[15] H. Erlich,et al. MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.
[16] P. Marrack,et al. T cell tolerance by clonal elimination in the thymus , 1987, Cell.
[17] G. Salama,et al. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. , 1993, The Journal of clinical investigation.
[18] D. Stage,et al. HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. , 1989, Arthritis and rheumatism.
[19] A. Sette,et al. Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide , 1995, The Journal of experimental medicine.
[20] M. Yaron,et al. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. , 1982, Annals of the rheumatic diseases.
[21] F. Sinigaglia,et al. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries , 1992, The Journal of experimental medicine.
[22] Y. Uematsu,et al. Thymic major histocompatibility complex antigens and the αβ T-cell receptor determine the CD4/CD8 phenotype of T cells , 1988, Nature.